Atlantic International (ATLN) AI Stock Analysis

• Market Cap: $131.32M
• Dividend Yield: N/A
• Average Volume (3M): 53.77K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.20
• Revenue Growth: N/A
• EPS Growth: 73.28%
• Country: US
• Employees: 300
• Sector: Healthcare
• Sector Strength: 39
• Industry: Medical - Diagnostics & Research
• EPS (TTM): -6.27
• Shares Outstanding: 61,650,547
• 10 Day Avg. Volume: 114,284
• 30 Day Avg. Volume: 53,774
• PEG Ratio: -0.08
• Price to Book (P/B): 0.79
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.93
• Enterprise Value/Market Cap: 0.03
• Enterprise Value/Revenue: <0.01
• Enterprise Value/Gross Profit: 0.12
• Enterprise Value/Ebitda: -0.02
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 42 Neutral
• Price Target: $2.00 ▼(-6.10%Downside)

Atlantic International's overall stock score is significantly impacted by its poor financial performance, which poses major risks to investors. The weak technical analysis further underscores bearish momentum. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, leaving little room for positive outlook.

Atlantic International Business Overview & Revenue Model

Company Description

As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.

How the Company Makes Money

Atlantic International generates revenue through multiple streams, primarily from its shipping and logistics services. The company's earnings are driven by contracts with multinational corporations requiring global transportation solutions, where it charges fees for freight transport, warehousing, and distribution services. Additionally, ATLN benefits from strategic partnerships with major shipping lines and port authorities, allowing it to optimize operations and reduce costs. The company also invests in technology and infrastructure to enhance its supply chain capabilities, further contributing to its revenue growth.

Atlantic International Financial Statement Overview

Summary

Atlantic International is facing significant financial difficulties across all verticals. The company struggles with profitability, financial stability, and liquidity, suggesting potential risks for investors.

Income Statement

Atlantic International has faced significant revenue volatility, with periods of zero revenue and negative growth in some years. The company consistently reports negative net income and margins, indicating ongoing struggles with profitability.

Balance Sheet

The company exhibits a high debt-to-equity ratio due to negative equity, reflecting financial instability and potential solvency issues. Negative stockholders' equity further highlights the company's financial distress.

Cash Flow

The cash flow situation is concerning, with negative free cash flow and operating cash flow. The company is not generating sufficient cash to cover its operations, indicating liquidity challenges.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	442.61M	401.37M	78.66K	210.00K	329.50K
Gross Profit	47.18M	46.88M	-121.95K	65.86K	158.69K
EBITDA	-113.10M	1.40M	-3.80M	-3.41M	-649.39K
Net Income	-135.48M	-15.25M	-4.09M	-3.70M	-1.05M
Balance Sheet
Total Assets	122.75M	126.67M	8.41M	10.74M	694.04K
Cash, Cash Equivalents and Short-Term Investments	678.68K	1.35M	6.22M	9.95M	0.00
Total Debt	82.72M	142.62M	2.93M	1.38M	3.56M
Total Liabilities	134.77M	166.02M	4.05M	2.56M	4.55M
Stockholders Equity	-12.02M	-39.35M	4.37M	8.18M	-3.85M
Cash Flow
Free Cash Flow	-6.06M	-9.16M	-3.70M	-2.00M	-757.91K
Operating Cash Flow	-5.99M	-9.08M	-3.66M	-1.99M	-757.91K
Investing Cash Flow	-73.46K	-73.71K	1.83M	-5.99M	0.00
Financing Cash Flow	5.38M	8.79M	0.00	12.00M	752.05K

Atlantic International Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.13
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ATLN, the sentiment is Negative. The current price of 2.13 is below the 20-day moving average (MA) of 2.35, below the 50-day MA of 2.70, and below the 200-day MA of 4.25, indicating a bearish trend. The MACD of -0.19 indicates Positive momentum. The RSI at 42.58 is Neutral, neither overbought nor oversold. The STOCH value of 31.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ATLN.

Atlantic International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PSNL	60 Neutral	$658.02M	―	-51.25%	―	15.57%	31.82%
MDXH	57 Neutral	$108.40M	―	-1552.23%	―	25.46%	21.83%
SERA	52 Neutral	$93.81M	―	-41.36%	―	-44.17%	12.77%
Sector *	52 Neutral	$7.50B	0.31	-61.87%	2.27%	17.10%	1.59%
ACRS	46 Neutral	$155.92M	―	-91.03%	―	-40.09%	-18.67%
STIM	43 Neutral	$223.79M	―	-152.14%	―	22.16%	-37.60%
ATLN	42 Neutral	$131.32M	―	-715.34%	―	―	73.28%

Atlantic International Corporate Events

Atlantic International Secures $70M Credit Facility

On April 29, 2025, Atlantic International Corp.’s subsidiary, Lyneer Staffing Solutions, LLC, entered into a Loan and Security Agreement with North Mill Capital, LLC, providing a $70 million senior secured revolving credit facility. This agreement replaced a prior facility with BMO Bank and includes customary covenants and conditions for credit facilities of this type. The agreement is set to mature on April 29, 2028, with potential for extension, and involves guarantees from Lyneer Holdings, Inc. and Lyneer Investments, LLC. Additionally, Prateek Gattani resigned as Chairman of the Board of Directors in consideration of the Loan Agreement.